About the pathways to deliver brimonidine to the Muller’s muscle

About the pathways to deliver brimonidine to the Muller’s muscle

Bibliographic Details
Main Authors:	Soha Ghanian, MD, Sarah P.F. Wambier, MD, PhD, Fernando Procianoy, MD, PhD, Carlos G. Wambier, MD, PhD
Format:	Article
Language:	English
Published:	Elsevier 2023-03-01
Series:	JAAD Case Reports
Subjects:	adverse event blepharoptosis botulinum toxin brimonidine eye ptosis Muller’s muscle
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352512623000036

Similar Items

An Alternative Algorithm for Müller Muscle Conjunctival Resection Surgery for Blepharoptosis Management
by: Gamze Ozturk Karabulut, et al.
Published: (2019-12-01)

Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil
by: Inoue K, et al.
Published: (2024-02-01)

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study
by: Alex T. Pham, BS, et al.
Published: (2023-01-01)

Efficacy of modified levator-muscle resection using Putterman ptosis clamp versus traditional levator-muscle resection for aponeurotic ptosis: A retrospective analysis
by: Ju-Wen Yang, et al.
Published: (2022-08-01)

Brimonidine Eye Drops within the Reach of Children: A Possible Foe
by: Daniela Trotta, et al.
Published: (2024-03-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

The Prevalence and Severity of Acquired Blepharoptosis in US Eye Care Clinic Patients and Their Receptivity to Treatment [Letter]
by: Rajput T, et al.
Published: (2024-04-01)

The Prevalence and Severity of Acquired Blepharoptosis in US Eye Care Clinic Patients and Their Receptivity to Treatment
by: Matossian C
Published: (2024-01-01)

Neuroprotective properties of Brimonidine
by: Т. N. Mikhailova
Published: (2019-11-01)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2022-12-01)

A Fully Automatic Postoperative Appearance Prediction System for Blepharoptosis Surgery with Image-based Deep Learning
by: Yiming Sun, MD, et al.
Published: (2022-09-01)

Difference in vasoconstrictors: oxymetazoline vs. brimonidine
by: Nwanneka Okwundu, et al.
Published: (2021-02-01)

Emerging Medical Therapies in Rosacea: A Narrative Review
by: James Choe, et al.
Published: (2023-10-01)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2021-11-01)

Brimonidine as a possible treatment for myopia
by: Zixuan Peng, et al.
Published: (2024-04-01)

Nummular keratitis: A rare manifestation of brimonidine allergy
by: Maitha Al Asmi, et al.
Published: (2024-01-01)

Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial
by: Anubha Bhatti, et al.
Published: (2018-01-01)

Evaluation of Foveal Cone and Müller Cells in Epiretinal Membrane using Adaptive Optics OCT
by: Masaharu Ishikura, MD, et al.
Published: (2024-01-01)

Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension
by: A. V. Sidorova, et al.
Published: (2021-07-01)

Oxymetazoline hydrochloride ophthalmic solution, 0.1%, boosts the effects of botulinum toxin on blepharospasm: a case series
by: Jonathan Sung, et al.
Published: (2022-08-01)

Successful treatment of ulcerated infantile hemangioma with brimonidine-timolol cream: 2 cases report and review of the literature
by: Mishal Almebayadh
Published: (2020-05-01)

Results of surgical treatment of ptosis of the upper eyelid by the dosed muscle-conjunctival resection of the upper cartilage
by: M. M. Bikbov, et al.
Published: (2023-03-01)

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
by: Oya Tekeli, et al.
Published: (2022-08-01)

Topical brimonidine induced acute uveal effusion in a patient with nanophthalmos: a case report
by: Yakun Li, et al.
Published: (2023-10-01)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
by: Haonan Xu, et al.
Published: (2023-01-01)

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
by: Thomas Ravi, et al.
Published: (2003-01-01)

Comparative Analysis of Pupil Diameters in Light and Dark Conditions After Instillation of 0.15% Brimonidine Drops in Eyes With and Without Pseudoexfoliation Syndrome
by: Sercan Cate, et al.
Published: (2020-12-01)

Traumatic ptosis: Evaluation of etiology, management and prognosis
by: Sarah Mireles Jacobs, et al.
Published: (2018-01-01)

Botulinum toxin A as an alternative treatment for folliculitis decalvans
by: Simone R.N.G. Neri, MD, et al.
Published: (2023-05-01)

Botulinum toxin A versus microwave thermolysis for primary axillary hyperhidrosis: A randomized controlled trialCapsule Summary
by: Gabriela Lladó Grove, MD, et al.
Published: (2024-06-01)

Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis
by: Eriko Kunikane, et al.
Published: (2023-09-01)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
by: Yusuke Orii, et al.
Published: (2023-06-01)

Evaluating the Correlation between Ptosis Improvement and Immediate Postoperative Lagophthalmos following Blepharoptosis Surgery under General Anesthesia in Pediatric Patients
by: Jae Hoon Jeong, et al.
Published: (2024-02-01)

Botulism Presented with Clinical Head Drop, Approach to Botulinum Toxin A: A Case Report
by: Kemal İzzettin Barkut, et al.
Published: (2023-12-01)

Ultra-Long-Term Therapy of Benign Essential Blepharospasm with Botulinumtoxin A—30 Years of Experience in a Tertiary Care Center
by: Bettina Wabbels, et al.
Published: (2022-02-01)

Botulinum toxin type A for cephalic cutaneous allodynia in chronic migraine: a randomized, double-blinded, placebo-controlled trial
by: Luciano Hollanda, et al.
Published: (2014-12-01)

Muscle-Sparing Blepharoplasty: A Prospective Left-Right Comparative Study
by: Lee Kiang, et al.
Published: (2014-09-01)

Prevention of hematomas in the induction of injection cosmetology interventions
by: M. V. Zhuchkov, et al.
Published: (2019-04-01)

Pneumonitis During Durvalumab Consolidation Therapy Affects Survival in Stage III NSCLC
by: Yuhei Kinehara, MD, PhD, et al.
Published: (2023-11-01)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
by: Jing Yang, et al.
Published: (2023-05-01)